272 related articles for article (PubMed ID: 20719947)
1. Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.
Sivachandran N; Cao JY; Frappier L
J Virol; 2010 Nov; 84(21):11113-23. PubMed ID: 20719947
[TBL] [Abstract][Full Text] [Related]
2. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
Frappier L
Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
Sivachandran N; Sarkari F; Frappier L
PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
[TBL] [Abstract][Full Text] [Related]
4. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
[TBL] [Abstract][Full Text] [Related]
5. The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.
Sarkari F; Wang X; Nguyen T; Frappier L
PLoS One; 2011 Jan; 6(1):e16598. PubMed ID: 21305000
[TBL] [Abstract][Full Text] [Related]
6. Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.
Sivachandran N; Wang X; Frappier L
J Virol; 2012 Jun; 86(11):6146-58. PubMed ID: 22491455
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.
Cao JY; Shire K; Landry C; Gish GD; Pawson T; Frappier L
Mol Cell Biol; 2014 Jan; 34(2):246-58. PubMed ID: 24216761
[TBL] [Abstract][Full Text] [Related]
8. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.
Sarkari F; Sanchez-Alcaraz T; Wang S; Holowaty MN; Sheng Y; Frappier L
PLoS Pathog; 2009 Oct; 5(10):e1000624. PubMed ID: 19834552
[TBL] [Abstract][Full Text] [Related]
9. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.
Holowaty MN; Zeghouf M; Wu H; Tellam J; Athanasopoulos V; Greenblatt J; Frappier L
J Biol Chem; 2003 Aug; 278(32):29987-94. PubMed ID: 12783858
[TBL] [Abstract][Full Text] [Related]
10. CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Choi S; Baldini C; Konstantinidou G; Pandolfi PP
Mol Cell Biochem; 2008 Sep; 316(1-2):149-54. PubMed ID: 18566754
[TBL] [Abstract][Full Text] [Related]
11. An Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies.
Komatsu T; Nagata K; Wodrich H
J Virol; 2016 Feb; 90(3):1657-67. PubMed ID: 26608315
[TBL] [Abstract][Full Text] [Related]
12. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
14. Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.
Sides MD; Block GJ; Chadwick RW; Shan B; Flemington EK; Lasky JA
Virol J; 2011 Oct; 8():461. PubMed ID: 21975125
[TBL] [Abstract][Full Text] [Related]
15. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer.
Chatterjee A; Chatterjee U; Ghosh MK
Cell Death Dis; 2013 Mar; 4(3):e543. PubMed ID: 23492774
[TBL] [Abstract][Full Text] [Related]
17. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
[TBL] [Abstract][Full Text] [Related]
18. Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.
Sides MD; Block GJ; Shan B; Esteves KC; Lin Z; Flemington EK; Lasky JA
Virology; 2011 Jul; 416(1-2):86-97. PubMed ID: 21605886
[TBL] [Abstract][Full Text] [Related]
19. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
Valentine R; Dawson CW; Hu C; Shah KM; Owen TJ; Date KL; Maia SP; Shao J; Arrand JR; Young LS; O'Neil JD
Mol Cancer; 2010 Jan; 9():1. PubMed ID: 20051109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
